The artificial intelligence (AI) model GPT-4, known from its application in ChatGPT, shows impressive capabilities in biomedical research and can be used in many ways for simulations. A simulator developed at MedUni Vienna and based on GPT-4 shows increased accuracy in classifying the importance of genes in cancer cells, as well as in the prognosis of cancer patients. The results of the study were published in the journal Computers in Biology and Medicine.
GAO offers 11 new policies to improve regenerative medicine development in new report
Companies that make regenerative medicines like CAR-T therapies, gene-edited stem cells and eye implants face a number of challenges that limit the development and use